Validation of Chinese Version Appropriate Use Criteria for Coronary Revascularization
Coronary revascularization (CR) is increasing rapidly in China and varies significantly in proportion ( PCI:CABG=15:1). Few studies assess the appropriateness of CR in China. Recently, National Center for Cardiovascular Disease organized experts to release Chinese version appropriate use criteria(C-AUC) for coronary revascularization by RAND method aimed at regulating indications of CR. The criteria is considered to contribute to clinical practices, quality assessment and health insurance policy, however, the validation of C-AUC is unknown.
Thus the investigators study aims at assessing the validation of Chinese AUC by multi-center prospective registry. The investigators will recruit 4000 patients undergoing elective coronary angiography with positive outcome consecutively and collect baseline information. Sequently, one-year follow up will be done to collect the prognose, including death, rehospitalization, medicine, medical compliance and life quality etc. One hand, the investigators will compare the outcomes between different therapies in the same indications according to C-AUC to evaluate the validation of C-AUC. On the other hand, the investigators will evaluate the rationality of CAD therapy in Beijing by C-AUC.
研究概览
地位
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
Beijing
-
Beijing、Beijing、中国
- Fuwai Hospital
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
Patients undergo elective coronary angiography in department of cardiology in period of study.
Patients are written informed consent.
描述
Inclusion Criteria:
- Undergo elective coronary angiography in department of cardiology in period of study
- Written informed consent
Exclusion Criteria:
- Age ≤18 years of age
- Illiteracy, vision/audition disorder, cognitive disorder etc
学习计划
研究是如何设计的?
设计细节
- 观测模型:队列
- 时间观点:预期
队列和干预
团体/队列 |
---|
appropriate in appropriate indications
|
inappropriate in appropriate indications
|
appropriate in inappropriate indications
|
inappropriate in inappropriate indications
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Major adverse cardiac and cerebrovascular events (MACCE)
大体时间:1 year
|
death, nonfatal myocardial infarction, cerebrovascular event, repeat revascularization
|
1 year
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
---|---|---|
死亡
大体时间:1年
|
1年
|
|
recurrent hospitalizations for acute coronary syndrome (ACS)
大体时间:1 year
|
1 year
|
|
cerebrovascular event
大体时间:1 year
|
1 year
|
|
repeat revascularization
大体时间:1 year
|
1 year
|
|
cost for hospitalization
大体时间:1 year
|
Total cost of hospitalization and rehospitalization for cardiac disease in follow-up time
|
1 year
|
合作者和调查者
出版物和有用的链接
一般刊物
- Lin S, Zhang H, Chen SP, Rao CF, Wu F, Zhou FJ, Wang Y, Yan HB, Dou KF, Wu YJ, Tang YD, Xie LH, Guan CD, Xu B, Zheng Z. Mis-estimation of coronary lesions and rectification by SYNTAX score feedback for coronary revascularization appropriateness. Chin Med J (Engl). 2020 Jun 5;133(11):1276-1284. doi: 10.1097/CM9.0000000000000827.
- Lin S, Zhang H, Rao CF, Chen SP, Qiao SB, Yan HB, Dou KF, Wu YJ, Tang YD, Yang XC, Shen ZJ, Liu J, Zheng Z; Beijing Coronary Angiography Registry Collaborative Group. Assessing the association of appropriateness of coronary revascularization and 1-year clinical outcomes for patients with stable coronary artery disease in China. Chin Med J (Engl). 2020 Jan 5;133(1):1-8. doi: 10.1097/CM9.0000000000000592.
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 2016-1-4031
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.